Phase 2 trials of antiviral pill show promising results in battling COVID-19
RN Todd Paul enters the apartment building and passes a sign calling for Covid-19 safety as he makes his way to visit his veteran/patient’s home in Boston, Massachusetts on March 4, 2021. Photo by JOSEPH PREZIOSO/AFP via Getty Images)
OAN Newsroom
UPDATED 1:16 PM PT – Wednesday, March 10, 2021
Two American companies teamed up to produce an anti-viral pill used to combat the coronavirus. According to recent reports, the drug molnupiravirperf performed well in early-stage trials.
Ridgeback Biotherapeutics and Merck said their pill is a five day, at-home treatment aimed to reduce the damage done by the virus as well as cut down on the time it takes to receive a negative test after being infected.
A man walks by a sign at a Merck plant in Rahway, New Jersey. (Photo by Marko Georgiev/Getty Images)
Researchers are optimistic about the pill’s capabilities.
“It might be one of those drugs, fingers crossed, that it doesn’t matter what virus you have,” USF Associate Professor of Pediatrics Medicine Michael Teng Ph.D. stated. “If you have these respiratory symptoms, take this drug, it will probably hit that virus.”
Doctors that have studied the medication are calling it a potential “holy grail.” They noted it could be made available in the next four to five months.
MORE NEWS: SFPD Arrest Man Suspected Of Robbing Reporter In Bay Area
" Conservative News Daily does not always share or support the views and opinions expressed here; they are just those of the writer."
